CVS acquisition of Aetna may not face antitrust challenges
U.S. antitrust enforcers might not move to block CVS Health’s acquisition of health insurance company Aetna, Bloomberg reported. The news, which was fueled from a report by Reorg Research, spiked shares of both companies last week.
Justice Department staff are expected to support approval of the $69 billion deal, which was announced in December 2017 and approved by shareholders of both companies in March.
Read the full story below: